Magellan Diagnostics, Inc.

Form 483 issued June 29, 2017 · North Billerica, Massachusetts

Inspection
May 10 – Jun 29, 2017
Observations
9
Pages
11
FEI number
1218996

In short: On June 29, 2017, FDA issued a Form 483 with 9 observations to Magellan Diagnostics, Inc. in North Billerica, Massachusetts (FEI 1218996) after an inspection that ran May 10 – Jun 29, 2017. The investigators were James W. Whitney and Suzanne M. Healy. Most observations concern cAPA and design controls; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

CAPA and design controls account for 9 of 9 observations.

CAPA5
Design controls4

Most cited: 21 CFR 820.30(g) (3×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Design validation did not ensure the device conforms to defined user…

  2. 02

    Risk analysis is…

  3. 03

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have…

  4. 04

    Procedmes for con ective and preventive action have…

5 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Magellan Diagnostics, Inc.?

FDA listed 9 observations on this Form 483, mostly about cAPA and design controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Magellan Diagnostics, Inc.?

James W. Whitney and Suzanne M. Healy are named on this Form 483, for the inspection of May 10 – Jun 29, 2017. Each investigator has a profile showing what they cite most.

When was Magellan Diagnostics, Inc. inspected by FDA?

The inspection ran May 10 – Jun 29, 2017, and the Form 483 is dated June 29, 2017.

How do I get the full Form 483 for Magellan Diagnostics, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free